Regeneron: Covid-19 clinical trial begins
(CercleFinance.com) - Regeneron Pharmaceuticals has announced that it has begun the first clinical trial for REGN-COV2, an investigational "cocktail" of two antibodies for the prevention and treatment of Covid-19.
This program will consist of four separately studied populations: two for treatment and two for prevention. The first two studies will evaluate safety and efficacy in both inpatients and outpatients.
Copyright (c) 2020 CercleFinance.com. All rights reserved.